November 30 - December 1, 2022
Digital Conference8:00AM EST // 1:00PM GMT // 2:00PM CET Angelica LoskogProfessor of Immunotherapy & Chief Executive Officer/Chief Scientific Officer at Uppsala University & Lokon Pharma AB, SwedenSpeaker
Profile
Angelica Loskog is the CEO of Lokon Pharma and a Professor of immunotherapy at Uppsala University in Sweden. Further, she is a scientific advisor to the venture capital company Nexttobe AB and is a board member of several of their portfolio companies. Dr Loskog did her postdoc at Baylor College of Medicine, Texas, and her research focuses to develop immunostimulatory gene therapy of cancer utilizing oncolytic viruses, and gene engineering of CAR T cells.
Agenda Sessions
Targeting the CD40 and 4-1BB Pathways Using LOAd703 Virotherapy
, 12:35pmView Session